Viewing Study NCT04552951


Ignite Creation Date: 2025-12-24 @ 11:43 PM
Ignite Modification Date: 2026-02-22 @ 3:42 AM
Study NCT ID: NCT04552951
Status: UNKNOWN
Last Update Posted: 2020-09-17
First Post: 2020-05-21
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Effect of Vitamin D on Morbidity and Mortality of the COVID-19
Sponsor: Fundación para la Investigación Biosanitaria del Principado de Asturias
Organization:

Study Overview

Official Title: Estudio Destinado a Valorar la Utilidad de Vitamina D Sobre Morbilidad y Mortalidad de la infección Por Virus SARS-COV-2 (COVID-19) en el Hospital Universitario Central de Asturias
Status: UNKNOWN
Status Verified Date: 2020-09
Last Known Status: RECRUITING
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: COVID-VIT-D
Brief Summary: Patients diagnosed of COVID-19 disease are randomized to receive a single dose of 100.000 IU of Cholecalciferol (Vitamin D arm) or no vitamin D (on top of the current medication used to treat COVID 19).

Clinical, radiological and biochemical outcomes of COVID 19 disease as well as mortality are evaluated.
Detailed Description: Efficacy parameters to compare both groups (vitamin D and No vitamin D).

Time to reach undetectable levels of SARS COV2 Infection.

Time of normalization of symptoms and clinical parameters.

Time of normalization of radiological images.

Time of normalization of biochemical markers.

Time of normalization of molecular inflammatory markers.

Transfer to the Intensive care Unit.

Mortality rate.

Study Oversight

Has Oversight DMC: True
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: